A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which was already widely used in a country ...

New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer. Ozempic, the cancer ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

New analyses of an investigational high-dose semaglutide pill for obesity showed improvements in blood sugar control and ...

A new study suggests GLP-1 receptor agonists like Ozempic and Wegovy may significantly improve colon cancer survival rates. Researchers observed a lower five-year mortality among users, particularly ...

Gladiator's Russell Crowe said reducing his alcohol intake helped him lose nearly 60 pounds in one year: "I try not to have ...

Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...